Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Card Surg ; 37(3): 693-696, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34964159

ABSTRACT

In this report, we describe a 25-year-old patient in whom a fistula between the right pulmonary artery and the left atrium was accurately diagnosed. The successful surgical management of this patient is described. Current diagnostic methods, evaluation, and treatment options for this uncommon cause of cyanosis in an adult patient are discussed.


Subject(s)
Fistula , Pulmonary Artery , Adult , Cardiac Catheterization , Cyanosis , Fistula/diagnostic imaging , Fistula/surgery , Heart Atria/diagnostic imaging , Heart Atria/surgery , Humans , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/surgery
2.
J Cardiothorac Vasc Anesth ; 27(6): 1201-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24050855

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of tranexamic acid (TXA) versus epsilon aminocaproic acid (EACA) in patients undergoing thoracic aortic surgery. DESIGN: A prospective randomized study. SETTING: A tertiary care center. PARTICIPANT: The study was conducted on 64 consecutive adult patients undergoing thoracic aortic surgery with cardiopulmonary bypass (CPB). INTERVENTIONS: Group EACA received a bolus of 50 mg/kg of EACA after induction of anesthesia over 20 minutes followed by maintenance infusion of 25 mg/kg/h until chest closure. Group TXA received a bolus of 10 mg/kg of TXA after induction of anesthesia over 20 minutes followed by maintenance infusion of 1 mg/kg/h until chest closure. MEASUREMENTS AND MAIN RESULTS: Cumulated mean blood loss, total packed red blood cells, and blood product requirement up to 24 h postoperatively were comparable between groups. A significant renal injury (EACA 40% v TXA 16%; p = 0.04) and increased tendency for renal failure (EACA 10% v TXA 0%, p = 0.11; relative risk 2.15) were observed with EACA compared to TXA. There was increased tendency of seizure with TXA (EACA v TXA: 3.3% v 10%; p>0.05, relative risk 1.53). There was significant increase in the D-dimer from preoperative to postoperative values in Group EACA. (p< 0.01). CONCLUSIONS: Both EACA and TXA were equally effective in reducing the perioperative blood loss and transfusion requirement in patients undergoing thoracic aortic surgery. While significant renal injury was observed with EACA, there was a tendency for higher incidence of seizure with TXA. Prospective placebo-controlled trials recruiting larger sample size using sensitive biomarkers are required before any recommendations.


Subject(s)
Aminocaproic Acid/therapeutic use , Antifibrinolytic Agents/therapeutic use , Aorta, Thoracic/surgery , Blood Loss, Surgical/prevention & control , Tranexamic Acid/therapeutic use , Vascular Surgical Procedures/methods , Adult , Aminocaproic Acid/adverse effects , Antifibrinolytic Agents/adverse effects , Blood Transfusion/methods , Cardiopulmonary Bypass/methods , Female , Fibrin Fibrinogen Degradation Products/analysis , Humans , Male , Middle Aged , Postoperative Care , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Prospective Studies , Renal Insufficiency/epidemiology , Renal Insufficiency/etiology , Sample Size , Tranexamic Acid/adverse effects , Vascular Surgical Procedures/mortality
SELECTION OF CITATIONS
SEARCH DETAIL